Very promising. Unfortunately Covid19 delays.

"Although initially expected to be completed by December 2020, the ongoing COVID-19 pandemic has currently halted all patient recruitment for clinical trials, and it is now likely that the APPRoAcH-p trial will not be completed until 2021. In terms of a phase 2 trial, Dr. Provencher indicated that “many centers have already been identified worldwide to complete the [phase 2] trial. We also have the funding to do it, and we expected it to be launched by the end of 2020. Now, it’s more likely to be the first half of 2021.”"